Investor · Bozeman, MT

Zafrira Avnur

Open Zafrira in the network graph →

Filings

7

SEC Form D

Connections

56

co-filers

Capital

$97.0M

across filings

Active

Jan 2017

to Mar 2021

Most-connected co-filers (56)

Pushkal W. Garg · Watertown, MA2 shared Alon Lazarus · Cambridge, MA2 shared Eric D. Moessinger · Boston, MA2 shared Armon Sharei, Ph.D · Boston, MA2 shared Jasbir S. Seehra · Lexington, MA2 shared Marc W. Elia · Watertown, MA2 shared Amy W. Schulman · Cambridge, MA2 shared Jonathan Fleming · Lexington, MA2 shared Klavs F. Jensen, Ph.D · Boston, MA2 shared Richard T. Miller · Boston, MA1 shared Julius S. Knowles · Lexington, MA1 shared Kevin M. Morse · Merrillville, IN1 shared Ran S. Nussbaum · Lexington, MA1 shared Dave R. Maness · Charleston, SC1 shared Jason Harmon · Bozeman, MT1 shared Alessandro M. Boninsegna · New York, NY1 shared Juan J. De Abreu Macedo · Miami, FL1 shared Karim Lalji · Bozeman, MT1 shared Daniel M. Freeman · London, United Kingdom1 shared Francisco J. Gonzalez · Miami, FL1 shared Patricia W. Seminario · Portland, OR1 shared Richard J. Trabulsi · New York, NY1 shared Pauline A. Murphy · Rocky Hill, CT1 shared Julius Knowles · Cambridge, MA1 shared

Recent filings (7)

Variantyx Inc.Mar 2021 · 9 co-filers$20.1M Variantyx Inc.Mar 2021 · 9 co-filers$20.1M SQZ Biotechnologies CoJun 2020 · 27 co-filers$70.2M SQZ Biotechnologies CoJun 2020 · 27 co-filers$70.2M Keros Therapeutics, Inc.Mar 2020 · 18 co-filers$56.0M Keros Therapeutics, Inc.Mar 2020 · 18 co-filers$56.0M SQZ Biotechnologies CoNov 2019 · 21 co-filers SQZ Biotechnologies CoNov 2019 · 21 co-filers Keros Therapeutics, Inc.Nov 2018 · 16 co-filers$23.0M Keros Therapeutics, Inc.Nov 2018 · 16 co-filers$23.0M Bioarray Genetics, Inc.Sep 2017 · 10 co-filers$5.2M Bioarray Genetics, Inc.Sep 2017 · 10 co-filers$5.2M Microbion CorpJan 2017 · 9 co-filers$51.3M Microbion CorpJan 2017 · 9 co-filers$51.3M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Zafrira in the interactive graph →